Topics

Azafaros B.V. Company Profile

23:35 EST 26th February 2020 | BioPortfolio

Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modifying potential. Based on discoveries from Leiden University and Amsterdam UMC, Azafaros' proprietary lead compound AZ-3102 will initially address inherited life-threatening lysosomal storage diseases for which there are no effective therapies today. This orally available azasugar compound interferes with the metabolism of glycolipids and uniquely affects several key disease pathways through a dual mode of action. Leveraging the know-how of its team and partners in orphan drug development, the company is advancing its lead program toward first-in-man studies while further expanding its product pipeline into other rare metabolic diseases through its drug discovery efforts. For more information, please visit www.azafaros.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Series A brings in €25M for Azafaros

Metabolic-focused start-up Azafaros BV raised €25M ($28M) through its Series A financing led by Forbion, which was joined by BioMedPartners and BioGeneration Ventures. Representatives from each inve...

Funding round raises $28M for Azafaros

A Series A funding round produced $27.5 million for Azafaros, which is focused on developing its pipeline for rare metabolic  -More- 

Azafaros completes EUR25m Series A financing to advance rare metabolic disorders pipeline

This round was led by Forbion, with participation from BioMedPartners and founding investor BioGeneration Ventures (BGV). Azafaros was established in 2018 to translate innovative science from Leiden U...

Azafaros BV raises €25m in Series A round

Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline

Financing round led by Forbion with participation from BioMedPartners and founding investor BioGeneration Ventures Azafaros B.V. announced today the successful closing of its Series A financing r...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Azafaros B.V.

Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with diseas...

More Information about "Azafaros B.V." on BioPortfolio

We have published hundreds of Azafaros B.V. news stories on BioPortfolio along with dozens of Azafaros B.V. Clinical Trials and PubMed Articles about Azafaros B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Azafaros B.V. Companies in our database. You can also find out about relevant Azafaros B.V. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record